Purine-mediated signalling in pain and visceral perception

G Burnstock - Trends in pharmacological sciences, 2001 - cell.com
Trends in pharmacological sciences, 2001cell.com
Receptor subtypes for purines have been identified in a variety of tissues, increasing interest
in the roles of purine-mediated signalling in pathophysiological processes. Growing
evidence supports the involvement of one of the purinoceptor subtypes, P2X 3, in
nociception. In this article, recent studies of purine-mediated nociception and visceral pain
will be discussed. Furthermore, a novel hypothesis is proposed for purine-mediated
mechanosensory transduction where ATP released during distension from epithelial cells …
Abstract
Receptor subtypes for purines have been identified in a variety of tissues, increasing interest in the roles of purine-mediated signalling in pathophysiological processes. Growing evidence supports the involvement of one of the purinoceptor subtypes, P2X3, in nociception. In this article, recent studies of purine-mediated nociception and visceral pain will be discussed. Furthermore, a novel hypothesis is proposed for purine-mediated mechanosensory transduction where ATP released during distension from epithelial cells lining tubes (such as ureter and gut) and sacs (such as the bladder) acts on P2X3 receptors on a subepithelial nerve plexus to initiate impulses that are relayed via the spinal cord to pain centres in the brain.
cell.com